125 related articles for article (PubMed ID: 6604578)
1. Identical efficacy of methotrexate regimens with N5-methyltetrahydrofolate rescue or with leucovorin rescue for treatment of L1210 murine leukemia.
Nixon PF; Wilson L
Cancer Treat Rep; 1983 Jan; 67(1):59-62. PubMed ID: 6604578
[No Abstract] [Full Text] [Related]
2. l-5-formyltetrahydrofolate and l-5-methyltetrahydrofolate rescue in L1210 leukemia treated with high methotrexate doses.
Simile MM; DeMiglio MR; Nufris A; Pascale RM; Muroni MR; Feo F
Res Commun Chem Pathol Pharmacol; 1993 Aug; 81(2):251-4. PubMed ID: 8210704
[TBL] [Abstract][Full Text] [Related]
3. Optimization of high-dose methotrexate with leucovorin rescue therapy in the L1210 leukemia and sarcoma 180 murine tumor models.
Sirotnak FM; Moccio DM; Dorick DM
Cancer Res; 1978 Feb; 38(2):345-53. PubMed ID: 304375
[TBL] [Abstract][Full Text] [Related]
4. Biochemical and pharmacokinetic effects of leucovorin after high-dose methotrexate in a murine leukemia model.
Sirotnak FM; Donsbach RC; Moccio DM; Dorick DM
Cancer Res; 1976 Dec; 36(12):4679-86. PubMed ID: 1087182
[TBL] [Abstract][Full Text] [Related]
5. High-dose methotrexate therapy with citrovorum factor: a pharmacologic perspective in murine tumor models.
Sirotnak FM; Donsbach RC; Dorick DM; Moccio DM
Cancer Treat Rep; 1977 Jul; 61(4):565-74. PubMed ID: 301778
[No Abstract] [Full Text] [Related]
6. New approach to antifolate treatment of certain cancers as demonstrated in tissue culture.
Halpern RM; Halpern BC; Clark BR; Ashe H; Hardy DN; Jenkinson PY; Chou SC; Smith RA
Proc Natl Acad Sci U S A; 1975 Oct; 72(10):4018-22. PubMed ID: 1081693
[TBL] [Abstract][Full Text] [Related]
7. Schedule-dependent synergism of methotrexate and vincristine against murine L1210 leukemia.
Chello PL; Sirotnak FM; Dorick DM; Moccio DM
Cancer Treat Rep; 1979; 63(11-12):1889-94. PubMed ID: 526921
[TBL] [Abstract][Full Text] [Related]
8. Clinical use of methotrexate--with emphasis on use of high doses.
Bertino JR
Cancer Treat Rep; 1981; 65 Suppl 1():131-5. PubMed ID: 6976829
[TBL] [Abstract][Full Text] [Related]
9. New approaches to chemotherapy with folate antagonists: use of leucovorin "rescue" and enzymic folate depletion.
Bertino JR; Levitt M; McCullough JL; Chabner B
Ann N Y Acad Sci; 1971 Nov; 186():486-95. PubMed ID: 4943812
[No Abstract] [Full Text] [Related]
10. New approaches to cancer chemotherapy with methotrexate.
Frei E; Jaffe N; Tattersall MH; Pitman S; Parker L
N Engl J Med; 1975 Apr; 292(16):846-51. PubMed ID: 1078714
[No Abstract] [Full Text] [Related]
11. The use of leucovorin orally in normal and leukemic L1210 mice to prevent the toxicity and gastrointestinal lesions caused by high doses of methotrexate.
Sandberg JS; Goldin A
Cancer Res; 1970 May; 30(5):1276-80. PubMed ID: 5310586
[No Abstract] [Full Text] [Related]
12. [Chemotherapy of L1210 leukemia: comparison of 7 drugs given either continuously for 20 days, or in a single massive dose, early or late].
Mathé G; Schwarzenberg L; Hayat M; Schneider M
Rev Fr Etud Clin Biol; 1968 Dec; 13(10):951-60. PubMed ID: 5306738
[No Abstract] [Full Text] [Related]
13. An apparent relationship between responsiveness to folinic acid protection from methotrexate cytotoxicity and uptake of 5-methyltetrahydrofolate in a series of murine cell lines.
Goldie JH; Hill BT
Cancer Biochem Biophys; 1979; 3(3):111-5. PubMed ID: 317897
[TBL] [Abstract][Full Text] [Related]
14. Combination chemotherapy in sequence for the treatment of L1210 leukemia.
Roberts D; Hilliard SL
Cancer Res; 1978 Aug; 38(8):2317-20. PubMed ID: 667827
[No Abstract] [Full Text] [Related]
15. Differential cell permeability and the basis for selective activity of methotrexate during therapy of the L1210 leukemia.
Sirotnak FM; Donsbach RC
Cancer Res; 1973 Jun; 33(6):1290-4. PubMed ID: 4718678
[No Abstract] [Full Text] [Related]
16. Disposition of leucovorin and its metabolites in the plasma, intestinal epithelium, and intraperitoneal L1210 cells of methotrexate-pretreated mice.
Bunni MA; Sirotnak FM; Otter GM; Priest DG
Cancer Chemother Pharmacol; 1994; 34(6):455-8. PubMed ID: 7923554
[TBL] [Abstract][Full Text] [Related]
17. Synergy between 5,10-dideaza-5,6,7,8-tetrahydrofolic acid and methotrexate in mice bearing L1210 tumors.
Ferguson K; Boschelli D; Hoffman P; Oronsky A; Whiteley J; Webber S; Galivan J; Freishiem J; Hynes J; Kerwar SS
Cancer Chemother Pharmacol; 1989; 25(3):173-6. PubMed ID: 2598407
[TBL] [Abstract][Full Text] [Related]
18. Effect of methotrexate with 5-methyltetrahydrofolate rescue and dietary homocystine on survival of leukemic mice and on concentrations of liver adenosylamino acids.
Hilton MA; Hoffman JL; Sparks MK
Cancer Res; 1983 Nov; 43(11):5210-6. PubMed ID: 6616457
[TBL] [Abstract][Full Text] [Related]
19. Increased schedule-dependent synergism of vindesine versus vincristine in combination with methotrexate against L1210 leukemia.
Chello PL; Sirotnak FM
Cancer Treat Rep; 1981; 65(11-12):1049-53. PubMed ID: 7296551
[TBL] [Abstract][Full Text] [Related]
20. Antifolate polyglutamylation and competitive drug displacement at dihydrofolate reductase as important elements in leucovorin rescue in L1210 cells.
Matherly LH; Barlowe CK; Goldman ID
Cancer Res; 1986 Feb; 46(2):588-93. PubMed ID: 2416428
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
